Hiroshi Arakawa

3.0k total citations · 1 hit paper
115 papers, 2.2k citations indexed

About

Hiroshi Arakawa is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Hiroshi Arakawa has authored 115 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 25 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Hiroshi Arakawa's work include Drug Transport and Resistance Mechanisms (28 papers), Liver physiology and pathology (13 papers) and 3D Printing in Biomedical Research (9 papers). Hiroshi Arakawa is often cited by papers focused on Drug Transport and Resistance Mechanisms (28 papers), Liver physiology and pathology (13 papers) and 3D Printing in Biomedical Research (9 papers). Hiroshi Arakawa collaborates with scholars based in Japan, United States and France. Hiroshi Arakawa's co-authors include Kazuhiro Sayama, Ikumi Tamai, Takeo Nakanishi, Hisao Tajiri, Takuo Ogihara, Kazuki Sumiyama, Kentarô Yano, N Kita, Michio Tsukamura and Mitsuru Kaise and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Hiroshi Arakawa

110 papers receiving 2.1k citations

Hit Papers

Uric acid in health and disease: From physiological funct... 2024 2026 2025 2024 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Uric acid in health and disease: From physiological functions to pathogenic mechanisms
    2024 100 citations Hiroshi Arakawa, Ikumi Tamai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Arakawa Japan 24 459 431 386 384 306 115 2.2k
Anjan Kumar Das India 33 302 0.7× 898 2.1× 259 0.7× 496 1.3× 620 2.0× 136 3.4k
Yasuo Hata Japan 27 356 0.8× 1.3k 2.9× 160 0.4× 449 1.2× 415 1.4× 97 2.8k
Zhen Zhou China 23 267 0.6× 482 1.1× 193 0.5× 243 0.6× 214 0.7× 172 2.2k
Yu‐Chen Fan China 30 397 0.9× 715 1.7× 400 1.0× 307 0.8× 258 0.8× 176 2.9k
Hitoshi Ishiguro Japan 38 656 1.4× 1.3k 3.1× 254 0.7× 386 1.0× 589 1.9× 107 3.8k
Jianqing Wang China 27 166 0.4× 706 1.6× 69 0.2× 323 0.8× 156 0.5× 97 2.1k
Jiayun Liu China 22 195 0.4× 676 1.6× 325 0.8× 153 0.4× 148 0.5× 105 1.7k
Junjie Zhu China 25 292 0.6× 1.1k 2.5× 88 0.2× 592 1.5× 195 0.6× 71 2.6k
Xuelian Li China 40 338 0.7× 2.9k 6.7× 185 0.5× 372 1.0× 300 1.0× 175 5.0k

Countries citing papers authored by Hiroshi Arakawa

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Arakawa more than expected).

Fields of papers citing papers by Hiroshi Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Arakawa. The network helps show where Hiroshi Arakawa may publish in the future.

Co-authorship network of co-authors of Hiroshi Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Arakawa. A scholar is included among the top collaborators of Hiroshi Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Arakawa. Hiroshi Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Hanwei, et al.. (2025). Role of organic anion transporter 2 in the efflux of raltegravir glucuronide from the endoplasmic reticulum in the liver. Biochemical Pharmacology. 242(Pt 1). 117230–117230.
2.
Inamatsu, Mutsumi, Hiroshi Arakawa, Yukio Kato, et al.. (2024). Gut–liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism. PNAS Nexus. 3(2). pgae070–pgae070. 8 indexed citations
3.
Isozumi, Noriyoshi, et al.. (2024). Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1. Journal of Pharmacology and Experimental Therapeutics. 390(1). 99–107. 1 indexed citations
4.
Arakawa, Hiroshi, et al.. (2024). Functional identification of soluble uric acid as an endogenous inhibitor of CD38. eLife. 13. 1 indexed citations
5.
Poulain, Stéphane, Masahiro Sugimoto, Hiroshi Arakawa, et al.. (2024). Mechanobiological stimulation in organ‐on‐a‐chip systems reduces hepatic drug metabolic capacity in favor of regenerative specialization. Biotechnology and Bioengineering. 121(4). 1434–1451. 1 indexed citations
6.
Arakawa, Hiroshi, et al.. (2024). Functional identification of soluble uric acid as an endogenous inhibitor of CD38. eLife. 13. 1 indexed citations
7.
8.
9.
Arakawa, Hiroshi, et al.. (2023). Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion. Communications Biology. 6(1). 866–866. 5 indexed citations
10.
Arakawa, Hiroshi, Takumi Nishiuchi, Makiko Meguro‐Horike, et al.. (2023). Renal Pharmacokinetic Adaptation to Cholestasis Causes Increased Nephrotoxic Drug Accumulation by Mrp6 Downregulation in Mice. Journal of Pharmaceutical Sciences. 112(12). 3209–3215. 1 indexed citations
11.
Arakawa, Hiroshi, et al.. (2022). Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening. Pharmaceutical Research. 39(7). 1549–1559. 4 indexed citations
12.
Arakawa, Hiroshi, et al.. (2021). CD38 activation by monosodium urate crystals contributes to inflammatory responses in human and murine macrophages. Biochemical and Biophysical Research Communications. 581. 6–11. 9 indexed citations
13.
Ito, Masaaki, et al.. (2020). Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein. PLoS ONE. 15(10). e0232438–e0232438. 8 indexed citations
14.
Arakawa, Hiroshi, et al.. (2020). Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models. Biomedicines. 8(10). 374–374. 25 indexed citations
15.
Koido, Shigeo, Sadamu Homma, Shin Kan, et al.. (2014). Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. International Journal of Oncology. 45(1). 470–478. 8 indexed citations
16.
Yano, Kentarô, et al.. (2014). A comparative examination of two pre-existing tablets and one double sized tablet from the view of both recipient and pharmacist. 43(2). 165–173. 1 indexed citations
17.
Arakawa, Hiroshi, Mitsuru Kaise, Kazuki Sumiyama, et al.. (2013). Does pulse oximetry accurately monitor a patient’s ventilation during sedated endoscopy under oxygen supplementation?. Singapore Medical Journal. 54(4). 212–215. 28 indexed citations
18.
Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions. OncoImmunology. 2(9). e25994–e25994. 11 indexed citations
19.
Nimura, Hiroshi, et al.. (2003). OBSERVATION ON SENTINEL LYMPH NODES USING AN INFRARED RAY EL, ECTRONIC ENDOSCOPIC SYSTEM. Acta gastro-enterologica belgica. 45(12). 2338–2345. 1 indexed citations
20.
Arakawa, Hiroshi, et al.. (2002). Hypergammaglobulinemic Purpura Occuring in a Female Delivered of an Infant Diagnosed with Neonatal Lupus Erythematosus.. The Nishinihon Journal of Dermatology. 64(4). 412–415. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anjan Kumar Das Breakdown of academic impact, for papers by Yasuo Hata Breakdown of academic impact, for papers by Zhen Zhou Breakdown of academic impact, for papers by Yu‐Chen Fan Breakdown of academic impact, for papers by Hitoshi Ishiguro Breakdown of academic impact, for papers by Jianqing Wang Breakdown of academic impact, for papers by Jiayun Liu Breakdown of academic impact, for papers by Junjie Zhu Breakdown of academic impact, for papers by Xuelian Li
Rankless by CCL
2026